-  - Diferencia - Volumen Bid- Ask- Capitalización de mecado Dividendo A. P/E Ratio
-SGD - -
Volumen de negocios: -
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 62 mil millonesSGD - -

Descripción de negocio

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only is the company a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens. Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities.
 

Consejo de gestión & Consejo de supervisión

CEO
Wolfgang Wienand
Consejo de gestión
Philippe Deecke, Gordon Bates, Jean-Christophe Hyvert, Maria Soler Nunez, Christian Seufert, Daniel Palmacci
Consejo de supervisión
Jean-Marc Huët, Juergen B. Steinemann, Angelica Kohlmann, Barbara M. Richmond, Christoph Mäder, Olivier Verscheure, Roger Nitsch, Marion Helmes
 

Datos de la empresa

Nombre: Lonza Group AG
Dirección: Münchensteinerstraße 38,Basel
Teléfono: +41-61-31681-11
Fax: +41-61-31691-11
E-mail: info@lonza.com
Internet: www.lonzagroup.com/
Industria: Biotechnology
Sector: Biotechnology
Subsector: Biotechnology
Fin del año financiero: 31/12
Acciones de libre circulación: 99.70%
Fecha de OPI: 02/11/1999

Relación con inversores

Nombre: Lyle Wheeler
IR teléfono: +41 79 154 9522
IR-fax: -
IR e-mail: investor.relations@lonza.com

Accionistas mayoritarios

Otros
 
83.90%
BlackRock, Inc
 
9.85%
UBS Fund Management (Switzerland) AG
 
6.25%